HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Hanxiao You Selected Research

R333

12/2020JAK Inhibitors: Prospects in Connective Tissue Diseases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Hanxiao You Research Topics

Disease

4Thrombocytopenia (Thrombopenia)
06/2022 - 01/2020
3Interstitial Lung Diseases (Interstitial Lung Disease)
06/2022 - 10/2021
3Dermatomyositis (Dermatopolymyositis)
06/2022 - 12/2020
2Arthritis (Polyarthritis)
10/2021 - 10/2019
2Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
01/2021 - 01/2021
2Systemic Lupus Erythematosus (Libman-Sacks Disease)
12/2020 - 10/2019
1Lymphopenia (Lymphocytopenia)
06/2022
1Lung Injury
02/2022
1Alopecia (Baldness)
11/2021
1Cicatrix (Scar)
11/2021
1Necrosis
08/2021
1Stroke (Strokes)
01/2021
1Diffuse Scleroderma (Progressive Systemic Sclerosis)
01/2021
1Hemorrhage
01/2021
1Rheumatoid Arthritis
12/2020
1Connective Tissue Diseases (Connective Tissue Disease)
12/2020
1Inflammation (Inflammations)
12/2020
1Opportunistic Infections (Opportunistic Infection)
12/2020
1Systemic Scleroderma (Systemic Sclerosis)
12/2020
1Vasculitis (Vasculitides)
12/2020
1Virus Diseases (Viral Diseases)
12/2020
1Leukopenia
01/2020
1Fibrosis (Cirrhosis)
01/2020
1Exanthema (Rash)
10/2019

Drug/Important Bio-Agent (IBA)

3AntibodiesIBA
06/2022 - 01/2021
3tofacitinibIBA
01/2021 - 10/2019
2Biomarkers (Surrogate Marker)IBA
02/2022 - 01/2021
2Phospholipids (Phosphatides)FDA LinkGeneric
08/2021 - 01/2021
1Hydroxychloroquine (Plaquenil)FDA LinkGeneric
06/2022
1IFIH1 Interferon-Induced HelicaseIBA
02/2022
1Immunosuppressive Agents (Immunosuppressants)IBA
11/2021
1AutoantibodiesIBA
10/2021
1Immunoglobulin G (IgG)IBA
01/2021
1C-Reactive ProteinIBA
01/2021
1Antiphospholipid AntibodiesIBA
01/2021
1Immunoglobulin A (IgA)IBA
01/2021
1Immunoglobulin M (IgM)IBA
01/2021
1CytokinesIBA
12/2020
12- ((2- (1H- pyrrolo(2,3- b)pyridin- 3- yl)pyrimidin- 4- yl)amino)- 2- methyl- N- (2,2,2- trifluoroethyl)butanamideIBA
12/2020
1peficitinibIBA
12/2020
1upadacitinibIBA
12/2020
1R333IBA
12/2020
1itacitinibIBA
12/2020
1beta-cyclodextrin tetradecasulfate (CTDS)IBA
12/2020
1ruxolitinibIBA
12/2020
1GLPG0634IBA
12/2020
1Janus Kinase InhibitorsIBA
12/2020
1Adrenal Cortex Hormones (Corticosteroids)IBA
12/2020
1baricitinibIBA
12/2020
1Immunoglobulins (Immunoglobulin)IBA
01/2020

Therapy/Procedure

1Therapeutics
01/2021